Childhood obesity and insulin resistance

Cell Biochemistry and Biophysics

Volumn 48, Issue 2-3, 2007, Pages 73-78

  Maclaren, Noel K ^a   Gujral, Sahil ^a   Ten, Svetlana ^a   Motagheti, Roja ^b  

^a MAIMONIDES MEDICAL CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Children at risk; Insulin like growth factor binding proteins; Insulin resistance; Insulin resistance syndrome; Obesity; Polycystic ovarian syndrome

Indexed keywords

IGFBP1 PROTEIN, HUMAN; INSULIN; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BLOOD; CHILD; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRESCHOOL CHILD; RISK FACTOR;

ADOLESCENT; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 2; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; METABOLIC SYNDROME X; OBESITY; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN;

EID: 34548314538     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-007-0017-6     Document Type: Article

References (25)

1. Reaven, G. (1988). Banting lecture. Role of insulin resistance in human disease. Diabetes, 37, 1595-1607.
2. Ten, S., & Maclaren, N. (2004). Insulin resistance syndrome in children. Journal of Clinical Endocrinology and Metabolism, 89(6), 2526-2539.
3. Kahn, R., Buse, J., Ferrannini, E., & Stern, M. (2005). The metabolic syndrome: Time for a critical appraisal. Diabetes Care, 28(9), 2289-2304.
4. Pankow, J., Jacobs, D., Steinberger, J., Moran, A., & Sinaiko, A. (2004). Insulin resistance and cardiovascular disease risk factors in children of parents with the insulin resistance (metabolic) syndrome. Diabetes Care, 27, 775-780.
5. National Institutes of Health (2001). Third report of the national cholesterol education program expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III). Bethesda, MD.
6. Ford, E., Giles, W., & Dietz, W. (2002). Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Examination Survey. JAMA, 287, 356-359.
7. World Health Organization - Department of Non-communicable Disease Surveillance (1999). Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus, in Definition diagnosis and classification of diabetes mellitus and its Complications (Alwan, A. and King, H. eds), World Health Organization, Geneva, Switzerland, pp. 1-59.
8. Cook, S., Weitzman, M., Auinger, P., Nguyen, M., & Dietz, W. (2003). Prevalence of a metabolic syndrome phenotype in adolescents: Findings from the third national health and Nutrition Examination Survey, 1988-1994. Archives of Pediartics & Adolescent Medicine, 157, 821-827.
9. Longmire, B., Sison, C., Ten, S., Motagheti, R., & Maclaren, N. (2005) Depressed IGFBP-1 levels in obese, insulin resistant children are associated with low birth weights. Abstract 2762, DIAEZ, 54(Supplement (1)), 1-A880.
10. Cummings, D., Clement, K., Purnell, J., Vaisse, C., Foster, K., Frayo, R., Schwartz, M., Basdevant, A., & Weigle, D. (2002). Elevated plasma ghrelin levels in Prader-Willi syndrome. Nature Medicine, 8, 643-644.
11. Grace, C., Beales, P., Summerbell, C., Jebb, S., Wright, A., Parker, D., & Kopelman, P. (2003). Energy metabolism in Bardet-Biedle syndrome. International Journal of Obesity and Related Metabolic Disorders, 27, 1319-1324.
12. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, and North American Association for the Study of Obesity (2004). Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care, 27, 596-601.
13. Bouchard, C. (1997). Genetic determinants of regional fat distribution. Human Reproduction, 12(suppl-1), 1-5.
14. Farooqui, I. S., Matarese, G., Lord, G., Keogh, J., Lawrence, E., Agwu, C., Sanna, V., Jebb, S., Perna, F., Fontana, S., Lechler, R., DePoali, A., & O'Rahilly, S. (2002). Beneficial effects of leptin on obesity, T cell hyporesponsiveness and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. Journal of Clinical Investigation, 110, 1093-1103.
15. Krude, H., Biebermann, H., & Gruters, A. (2003). Mutations in the human proopiomeanocortin gene. Annals of New York Academy of Sciences, 994, 233-239.
16. Damacott, C., Feingold, E., Moffett, S., Barada, M., Marshall, J., Hamman, R., & Ferrell, R. (2004). Genetic variation in uncoupling protein 3 is associated with dietary intake and body composition in females. Metabolism, 53, 458-464.
17. Krude, H., Biebermann, H., Schnabel, D., Tansek, M., Theunissen, P., Mullis, P., & Gruters, A. (2003). Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH 4-10. Journal of Clinical and Endocrinology and Metabolism, 88, 4633-4640.
18. Vaisse, C., Clement, K., Durand, E., Hercberg, S., Guy-Grand, B., & Frogel, P. (2000). Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. Journal of Clinical Investigation, 106, 253-262.
19. Le Stunff, C., Fallin, D., Schork, N., & Bougneres, P. (2000). The insulin gene VNTR is associated with fasting insulin levels and development of juvenile obesity. Nature Genetics, 26, 444-446.
20. Tiosano, D., Eisenstein, I., Militianu, D., Chrousos, G., & Hochberg, Z. (2003). 11-β Hydroxysteroid dehydrogenase activity in hypothalamic obesity. The Journal of Clinical Endocrinology and Metabolism, 88, 379-384.
21. Falkner, N., Neumark-Sztainer, D., Story, M., Jeffrey, R., Beuhring, T., & Resnick, M. (2003). Social marginization of overweight children. Archives of Pediartics & Adolescent Medicine, 157, 746-752.
22. Young, T., Peppard, P., & Gottlieb, D. (2002). Epidemiology of obstructive sleep apnea: A population based health perspective. American Journal of Respiratory and Critical Care Medicine, 165, 1217-1239.
23. Yanovski, J. (2001). Pediatric obesity. Reviews in Endocrine & Metabolic Disorders, 2, 371-383.
24. Harborne, L., Sattar, N., Norman, J., & Fleming, R. (2005). Metformin and weight loss in obese women with polycystic ovary syndrome: Comparison of doses. The Journal of Clinical Endocrinology and Metabolism, 90, 4593-4598.
25. Obesity Consensus Working Group (2005). Childhood Obesity. Journal of Clinical Metabolism, 90, 1871-1887.